I agree that this site is using cookies. You can find further informations here.
X
Railean, Violeta
26  results:
Search for persons X
?
1

Personalized medicine: Function of CFTR variant p.Arg334Trp..:

Railean, Violeta ; Rodrigues, Cláudia S. ; Ramalho, Sofia S....
Frontiers in Molecular Biosciences.  10 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
2

Synthesis and the In Vitro Evaluation of Antitumor Activity..:

Álvaro-Martins, Maria João ; Railean, Violeta ; Martins, Filomena...
Molecules.  28 (2023)  4 - p. 1877 , 2023
Link: https://doi.org/10.3390/..
 
?
3

Mutation-class dependent signatures outweigh disease-associ..:

Santos, Lúcia ; Nascimento, Rui ; Duarte, Aires...
Cell & Bioscience.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
4

Synthesis and the In Vitro Evaluation of Antitumor Activity..:

Maria João Álvaro-Martins ; Violeta Railean ; Filomena Martins...
https://www.mdpi.com/1420-3049/28/4/1877.  , 2023
Link: https://doi.org/10.3390/..
 
?
5

Synthesis and the in vitro evaluation of antitumor activity..:

Álvaro Martins, Maria Joao ; Railean, Violeta ; Martins, Filomena...
info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F00100%2F2020/PT.  , 2023
Link: http://hdl.handle.net/10..
 
?
6

Mutation-class dependent signatures outweigh disease-associ..:

Lúcia Santos ; Rui Nascimento ; Aires Duarte...
https://doi.org/10.1186/s13578-023-00975-y.  , 2023
Link: https://doi.org/10.1186/..
 
?
7

Personalized medicine: Function of CFTR variant p.Arg334Trp..:

Violeta Railean ; Cláudia S. Rodrigues ; Sofia S. Ramalho...
https://www.frontiersin.org/articles/10.3389/fmolb.2023.1155705/full.  , 2023
Link: https://doi.org/10.3389/..
 
?
8

Synthesis and the In Vitro Evaluation of Antitumor Activity..:

Maria João Álvaro-Martins ; Violeta Railean ; Filomena Martins...
Organic Chemistry.  , 2023
Link: https://doi.org/10.3390/..
 
?
9

The SLC26A9 inhibitor S9‐A13 provides no evidence for a rol..:

Jo, Sungwoo ; Centeio, Raquel ; Park, Jinhong...
The FASEB Journal.  36 (2022)  11 - p. , 2022
Link: https://doi.org/10.1096/..
 
?
10

Drug Repurposing for Cystic Fibrosis: Identification of Dru..:

Rodenburg, Lisa W. ; Delpiano, Livia ; Railean, Violeta...
International Journal of Molecular Sciences.  23 (2022)  20 - p. 12657 , 2022
Link: https://doi.org/10.3390/..
 
?
11

Systems Approaches to Unravel Molecular Function: High-cont..:

Pinto, Madalena C. ; Botelho, Hugo M. ; Silva, Iris A.L....
Journal of Molecular Biology.  434 (2022)  5 - p. 167436 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Drug Repurposing for Cystic Fibrosis: Identification of Dru..:

Rodenburg, Lisa W ; Delpiano, Livia ; Railean, Violeta...
1661-6596.  , 2022
Link: https://dspace.library.u..
 
?
13

The SLC26A9 inhibitor S9-A13 provides no evidence for a rol..:

Jo, Sungwoo ; Centeio, Raquel ; Park, Jinhong...
https://mediatum.ub.tum.de/1693400.  , 2022
Link: https://mediatum.ub.tum...
 
?
14

The SLC26A9 inhibitor S9-A13 provides no evidence for a rol..:

Jo, Sungwoo ; Centeio, Raquel ; Park, Jinhong...
0892-6638.  , 2022
Link: https://dspace.library.u..
 
?
15

Drug Repurposing for Cystic Fibrosis: Identification of Dru..:

Lisa W. Rodenburg ; Livia Delpiano ; Violeta Railean...
https://www.mdpi.com/1422-0067/23/20/12657.  , 2022
Link: https://doi.org/10.3390/..
 
1-15